Beigene Ltd
NASDAQ:ONC

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
NASDAQ:ONC
Watchlist
Price: 294.83 USD -0.26% Market Closed
Market Cap: 411B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

ONC Price Targets Summary
Beigene Ltd

Wall Street analysts forecast ONC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONC is 283.85 USD with a low forecast of 277.05 USD and a high forecast of 299.12 USD.

ONC Lowest Forecast
Wall Street Target
277.05 USD
6% Downside
ONC Average Forecast
Wall Street Target
283.85 USD
4% Downside
ONC Highest Forecast
Wall Street Target
299.12 USD
1% Upside
Lowest
Price Target
277.05 USD
6% Downside
Average
Price Target
283.85 USD
4% Downside
Highest
Price Target
299.12 USD
1% Upside
Beigene Ltd Competitors:
Price Targets
M
MGX
Metagenomi Inc
337% Upside
V
VTGN
VistaGen Therapeutics Inc
386% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
24% Upside
4974
Takara Bio Inc
28% Upside
M
MGX
Metagenomi Inc
337% Upside
V
VTGN
VistaGen Therapeutics Inc
386% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
24% Upside
4974
Takara Bio Inc
28% Upside
ATYR
aTyr Pharma Inc
238% Upside
603087
Gan & Lee Pharmaceuticals
7% Upside
A
ARMP
Armata Pharmaceuticals Inc
283% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
11% Downside

Revenue
Forecast

Revenue Estimate
Beigene Ltd

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 3 years is 23%.

56%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
ONC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONC stock valuation using valuation multiples.
Wall Street Estimates
ONC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONC's stock price target?
Price Target
283.85 USD

According to Wall Street analysts, the average 1-year price target for ONC is 283.85 USD with a low forecast of 277.05 USD and a high forecast of 299.12 USD.

What is Beigene Ltd's Revenue forecast?
Projected CAGR
23%

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 270,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.